Telix Pharmaceuticals reported AUD38.33M in Net Income for its fiscal semester ending in June of 2026.





Net Income Change Date
Cochlear AUD 161.5M 69.6M Dec/2025
CSL USD 401M 96.5M Dec/2025
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Mayne Pharma AUD -103.68M 68.4M Jun/2024
Medical Developments International AUD -226K 121K Dec/2025
Mesoblast USD -17.34M 22.82M Jun/2026
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Pacific Edge NZD -16.66M 2.45M Jun/2026
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
Polynovo AUD 3K 9.87M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Sonic Healthcare AUD 236.68M 82.29M Dec/2024